BROWN BROTHERS HARRIMAN & CO - HALOZYME THERAPEUTICS INC ownership

HALOZYME THERAPEUTICS INC's ticker is HALO and the CUSIP is 40637H109. A total of 214 filers reported holding HALOZYME THERAPEUTICS INC in Q1 2020. The put-call ratio across all filers is 0.66 and the average weighting 0.3%.

Quarter-by-quarter ownership
BROWN BROTHERS HARRIMAN & CO ownership history of HALOZYME THERAPEUTICS INC
ValueSharesWeighting
Q2 2023$13,743
-5.5%
3810.0%0.00%
Q1 2023$14,550
-32.9%
3810.0%0.00%
Q4 2022$21,679
-32.3%
381
-52.4%
0.00%
Q3 2022$32,000
-8.6%
8010.0%0.00%
Q2 2022$35,000
+483.3%
801
+134.2%
0.00%
Q4 2019$6,000
+20.0%
3420.0%0.00%
Q3 2019$5,0003420.00%
Other shareholders
HALOZYME THERAPEUTICS INC shareholders Q1 2020
NameSharesValueWeighting ↓
Third Security, LLC 19,816,162$191,226,0008.73%
BB BIOTECH AG 6,825,532$65,866,0002.13%
Lombard Odier Asset Management (USA) Corp 2,700,000$26,055,0001.79%
SECTORAL ASSET MANAGEMENT INC 3,724,351$35,940,0001.61%
QVT Financial LP 2,010,186$19,398,0000.97%
JHL Capital Group LLC 1,475,000$14,234,0000.94%
MAZAMA CAPITAL MANAGEMENT INC 358,087$3,456,0000.79%
EcoR1 Capital, LLC 160,700$1,551,0000.78%
Alden Global Capital Ltd 332,500$3,209,0000.77%
IRIDIAN ASSET MANAGEMENT LLC/CT 7,274,065$70,195,0000.65%
View complete list of HALOZYME THERAPEUTICS INC shareholders